Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers

FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence and OVA1, a multivariate panel consisting of CA-125 and four additional biomarkers, for referring patients to a specialist. Due to relatively poor performance of these tests, more accurate and broadly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Ping, Chen, Tzong-Hao, Seshaiah, Partha, Stephen, Laurie L., Michael-Ballard, Karri L., Mapes, James P., Mansfield, Brian C., Bertenshaw, Greg P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244467/
https://www.ncbi.nlm.nih.gov/pubmed/22216306
http://dx.doi.org/10.1371/journal.pone.0029533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244467/
https://www.ncbi.nlm.nih.gov/pubmed/22216306
http://dx.doi.org/10.1371/journal.pone.0029533

Ejemplares similares